MYOMA UTERI

myomauteri-1-0-25kapak

Coexistence of Myomas and Other Pathologies

Büşra Lekesiz1
Hüseyin Levent Keskin2

1Ankara Etlik City Hospital, Department of Gynecology and Obstetrics, Ankara, Türkiye
2Ankara Etlik City Hospital, Department of Gynecology and Obstetrics, Ankara, Türkiye

Lekesiz B, Keskin HL. Coexistence of Myomas and Other Pathologies. Yavuz AF, ed. Myoma Uteri. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.133-138.

ABSTRACT

Uterine myomas or myoma uteri (uterine leiomyomas) are the most common female pelvic neoplasms. They are benign tumors with monoclonal proliferation of smooth muscle and fibroblast cells of myometrium. They usually affect women in reproductive age. The pathological mechanisms causing leiomyoma development include some genetic factors and a hyperestrogenic environment. Other hyperestrogenic diseases like endometriosis, adenomyosis, and endometrial hyperplasia share some common molecular and genetic pathways with uterine leiomyomas and they commonly co-exist with uterine myomas. Subserosal growing uterine miyomas, especially myomas with cystic degeneration can mimic adnexal masses and cause difficulty in diagnosis. Patients with uterine leiomyomas should be evaluated and counseled extensively with the aspect that these conditions frequently accompany uterine leiomyomas.

Keywords: Leiomyoma; Endometriosis; Adenomyosis; Endometrial hyperplasia; Infertility

Referanslar

  1. Hemmings R, Rivard M, Olive DL, Poliquin-Fleury J, Gagné D, Hugo P, et al. Evaluation of risk factors associated with endometriosis. Fertil Steril. 2004;81(6):1513-21. [Crossref]  [PubMed]
  2. Huang JQ, Lathi RB, Lemyre M, Rodriguez HE, Nezhat CH, Nezhat C. Coexistence of endometriosis in women with symptomatic leiomyomas. Fertil Steril. 2010;94(2):720-3. [Crossref]  [PubMed]
  3. Uimari O, Järvelä I, Ryynänen M. Do symptomatic endometriosis and uterine fibroids appear together? J Hum Reprod Sci. 2011;4(1):34-8. [Crossref]  [PubMed]  [PMC]
  4. Prevalence and anatomical distribution of endometriosis in women with selected gynaecological conditions: results from a multicentric Italian study. Gruppo italiano per lo studio dell'endometriosi. Hum Reprod 1994; 9: 1158-62. [Crossref]  [PubMed]
  5. Maclaran K, Agarwal N, Odejinmi F. Co-existence of uterine myomas and endometriosis in women undergoing laparoscopic myomectomy: risk factors and surgical implications. J Minim Invasive Gynecol. 2014;21(6):1086-90. [Crossref]  [PubMed]
  6. Capezzuoli T, Vannuccini S, Fantappiè G, Orlandi G, Rizzello F, Coccia ME, et al. Ultrasound findings in infertile women with endometriosis: evidence of concomitant uterine disorders. Gynecol Endocrinol. 2020;36(9):808-12. [Crossref]  [PubMed]
  7. Tanmahasamut P, Noothong S, Sanga-Areekul N, Silprasit K, Dangrat C. Prevalence of endometriosis in women undergoing surgery for benign gynecologic diseases. J Med Assoc Thai. 2014;97(2):147-52. [Link]
  8. Bulun SE, Imir G, Utsunomiya H, Thung S, Gurates B, Tamura M, et al. Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol. 2005;95(1-5):57-62. [Crossref]  [PubMed]
  9. Baranov VS, Ivaschenko TE, Yarmolinskaya MI. Comparative systems genetics view of endometriosis and uterine leiomyoma: Two sides of the same coin? Syst Biol Reprod Med.2016;62(2):93-105. [Crossref]  [PubMed]
  10. Naphatthalung W, Cheewadhanaraks S. Prevalence of endometriosis among patients with adenomyosis and/or myoma uteri scheduled for a hysterectomyJ Med Assoc Thai. 2012;95(9):1136. [Link]
  11. Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis. F1000Res. 2019;8:F1000 Faculty Rev-283. [Crossref]  [PubMed]  [PMC]
  12. Brucker SY, Huebner M, Wallwiener M, Stewart EA, Ebersoll S, Schoenfisch B, et al. Clinical characteristics indicating adenomyosis coexisting with leiomyomas: a retrospective, questionnaire-based study. Fertil Steril. 2014;101(1):237-41. e1. [Crossref]  [PubMed]
  13. Taran F, Stewart E, Brucker S. Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd. 2013;73(09):924-31. [Crossref]  [PubMed]  [PMC]
  14. Taran FA, Weaver AL, Coddington CC, Stewart EA. Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study. Hum Reprod. 2010;25(5):1177-82. [Crossref]  [PubMed]  [PMC]
  15. Boeer B, Wallwiener M, Rom J, Schoenfisch B, Brucker SY, Taran FA. Differences in the clinical phenotype of adenomyosis and leiomyomas: a retrospective, questionnaire-based study. Arch Obstet Gynaecol. 2014;289:1235-9. [Crossref]  [PubMed]
  16. Taran FA, Wallwiener M, Kabashi D, Rothmund R, Rall K, Kraemer B, et al. Clinical characteristics indicating adenomyosis at the time of hysterectomy: a retrospective study in 291 patients. Arch Obstet Gynaecol. 2012;285:1571-6. [Crossref]  [PubMed]
  17. Taran FA, Weaver AL, Coddington CC, Stewart EA. Understanding adenomyosis: a case control study. Fertil Steril. 2010;94(4):1223-8. [Crossref]  [PubMed]  [PMC]
  18. Navarro A, Bariani MV, Yang Q, Al-Hendy A. Understanding the impact of uterine fibroids on human endometrium function. Front Cell Dev Biol. 2021;9:633180. [Crossref]  [PubMed]  [PMC]
  19. Landechowskij J, Al-Birawi A, Kulikov L. Characterisation of the endometrium in patients with uterus myoma. Zentralbl Gynakol. 1982;104(13):809-17. [PubMed]
  20. Teleman S, Mihailovici MS. Morphological correlations between endometrial hyperplasias, uterine leiomyoma and ovarian associated lesions. Rev Med Chir Soc Med Nat Iasi. 2003;107(2):379-82. [PubMed]
  21. Ciavattini A, Di Giuseppe J, Stortoni P, Montik N, Giannubilo SR, Litta P, et al. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int J. 2013;2013(1):173184. [Crossref]  [PubMed]  [PMC]
  22. Rotenberg O, Doulaveris G, Fridman D, Renz M, Kaplan J, Xie X, et al. Risk of endometrial polyp and surgical intervention in postmenopausal women with proliferative endometrium. Maturitas. 2023;178:107847. [Crossref]  [PubMed]
  23. Güngör ND, Önal M, Madenli AA, Ağar M. Surgical removal of FIGO type 0 and 1 fibroids ameliorates the expression of endometrial proinflammatory transcription factors and receptivity modulators. Fertil Steril. 2023;119(3):504-13. [Crossref]  [PubMed]
  24. Unlu C, Celik O, Celik N, Otlu B. Expression of endometrial receptivity genes increase after myomectomy of intramural leiomyomas not distorting the endometrial cavity. Reprod Sci. 2016;23(1):31-41. [Crossref]  [PubMed]
  25. Munro MG. Uterine polyps, adenomyosis, leiomyomas, and endometrial receptivity. Fertil Steril. 2019;111(4):629-40. [Crossref]  [PubMed]
  26. Moss E, Hollingworth J, Reynolds T. The role of CA125 in clinical practice. J Clin Pathol. 2005;58(3):308-12. [Crossref]  [PubMed]  [PMC]
  27. Kim SH, Sim JS, Seong CK. Interface vessels on color/ power Doppler US and MRI: a clue to differentiate subserosal uterine myomas from extrauterine tumors. J Comput Assist Tomogr. 2001;25(1):36-42. [Crossref]  [PubMed]
  28. Tower A, Rohrer R, Parmar R. Cystic Leiomyoma Mimicking Complex Adnexal Mass. J Minim Invasive Gynecol.2024 Sep 8:S1553-4650(24)00402-3. [Link]
  29. Yorita K, Tanaka Y, Hirano K, Kai Y, Arii K, Nakatani K, et al. A subserosal, pedunculated, multilocular uterine leiomyoma with ovarian tumor-like morphology and histological architecture of adenomatoid tumors: a case report and review of the literature. J Med Case Rep. 2016;10:1-7. [Crossref]  [PubMed]  [PMC]
  30. Carballo EV, Maturen KE, Li Z, Patel-Lippmann KK, Wasnik AP, Sadowski EA, et al. Surgical outcomes of adnexal masses classified by IOTA ultrasound simple rules. Sci Rep.2022;12(1):21848. [Crossref]  [PubMed]  [PMC]
  31. Zou L, Lou J, Huang H, Xu L. Pseudo-Meigs syndrome caused by a rapidly enlarging hydropic leiomyoma with elevated CA125 levels mimicking ovarian malignancy: a case report and literature review. BMC Women's Health. 2024;24(1):445. [Crossref]  [PubMed]  [PMC]
  32. Odaka H, Asahi R, Shimada K, Tokairin T, Kumazawa Y. Pseudo-Meigs' Syndrome in a Patient With Uterine Fibroids With Massive Pleural Effusion After Starting Gonadotropin-Releasing Hormone Agonist Therapy: A Case Report. Cureus. 2023;15(1). [Crossref]  [PMC]
  33. Almeida FT, Santos RP, Carvalho SD, Brito MC. Reed's syndrome. Indian J Dermatol. 2018;63(3):261-3. [Crossref]  [PubMed]  [PMC]
  34. MP GM, Pujol R, Alomar A, Calaf J, De Moragas J. Familial leiomyomatosis cutis et uteri (Reed's syndrome). Arch Dermatol Res. 1988;280:S29-32. [PubMed]
  35. Mandal RK, Koley S, Banerjee S, Kabiraj SP, Ghosh SK, Kumar P. Familial leiomyomatosis cutis affecting nine family members in two successive generations including four cases of Reed's syndrome. Indian J Dermatol Venereol Leprol. 2013;79:83. [Crossref]  [PubMed]
  36. Kontochristopoulos G, Kouris A, Balamoti E, Vavouli C, Markantoni V, Christofidou E, et al. A case of Reed's syndrome: an underdiagnosed tumor disorder. Kontochristopoulos G, Kouris A, Balamoti E, Vavouli C, Markantoni V, Christofidou E, et al. A case of Reed's syndrome: an underdiagnosed tumor disorder. Case Rep Dermatol. 2014;6(2):189-93. 2014;6(2):189-93. [Crossref]  [PubMed]  [PMC]
  37. Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomäki K, Tomlinson I, et al. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer. 2014;13:637-44. [Crossref]  [PubMed]  [PMC]
  38. Ooi A, editor Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research. Semin Cancer Biol; 2020: Elsevier. [Link]
  39. Ansari F, Al Assil T, Omaira M, Hoekstra AV. Myomatous erythrocytosis syndrome: a uterine fibroid associated with polycythaemia. BMJ Case Rep. 2024;17(3):e256927. [Crossref]  [PubMed]
  40. Mui J, Yang MM, Cohen T, McDonald DI, Hunt H. More than a myoma: a review of myomatous erythrocytosis syndrome. J Obstet Gynaecol Can. 2020;42(2):198-203. e3. [Crossref]  [PubMed]